Craving predicts opioid use in opioid-dependent patients initiating buprenorphine treatment: A longitudinal study

References

• Substance Abuse and Mental Health Services Administration. Results from the 2008 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-36, HHS Publication No. SMA 09-4434, Rockville, MD, 2009
   Google Scholar
• Hulse GK, English DR, Milne E, Holman CD. The quantification of mortality resulting from the regular use of illicit opiates. Addiction 1999;94:221–229
   PubMed Web of Science ®Google Scholar
• Mark TL, Woody GE, Juday T, Kleber HD. The economic costs of heroin addiction in the United States. Drug Alcohol Depend 2001;61:195–206
   PubMed Web of Science ®Google Scholar
• Stein MD. Medical consequences of substance abuse. Psychiatr Clin North Am 1999;22:351–370
   PubMed Web of Science ®Google Scholar
• Ling W, Wesson DR. Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Drug Alcohol Depend 2003;70:S49–57
   PubMed Web of Science ®Google Scholar
• Fareed A, Vayalapalli S, Casarella J, Amar R, Drexler K. Heroin anticraving medications: a systematic review. Am J Drug Alcohol Abuse 2010;36:332–341
   PubMed Web of Science ®Google Scholar
• Sayette MA, Shiffman S, Tiffany ST, Niaura RS, Martin CS, Shadel WG. The measurement of drug craving. Addiction 2000;95:S189–210
   PubMed Web of Science ®Google Scholar
• Tiffany ST, Wray JM. The clinical significance of drug craving. Ann N Y Acad Sci 2011;1248:1–17
   PubMed Web of Science ®Google Scholar
• Tiffany ST, Friedman L, Greenfield SF, Hasin DS, Jackson R. Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction 2011;107:709–718
   PubMed Web of Science ®Google Scholar
• Ling W, Charuvastra C, Collins JF, Batki S, Brown LS, Jr Kintaudi P, Wesson DR, et al. Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction 1998;93:475–486
   PubMed Web of Science ®Google Scholar
• Rosenberg H. Clinical and laboratory assessment of the subjective experience of drug craving. Clin Psychol Rev 2009;29:519–534
   PubMed Web of Science ®Google Scholar
• Franken IH, Hendriksa VM, van den Brink W. Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire. Addict Behav 2002;27:675–685
   PubMed Web of Science ®Google Scholar
• Flannery BA, Volpicelli JR, Pettinati HM. Psychometric properties of the Penn Alcohol Craving Scale. Alcohol Clin Exp Res 1999;23:1289–1295
   PubMed Web of Science ®Google Scholar
• Stein MD, Herman DS, Kettavong M, Cioe PA, Friedmann PD, Tellioglu T, Anderson BJ. Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons. J Subst Abuse Treat 2010;39:157–166
   PubMed Web of Science ®Google Scholar
• Miller I, Bishop S, Norman W, Maddever H. The modified Hamilton rating scale for depression: reliability and validity. Psych Res 1985;14:131–142
   PubMed Web of Science ®Google Scholar
• Flannery BA, Poole SA, Gallop RJ, Volpicelli JR. Alcohol craving predicts drinking during treatment: an analysis of three assessment instruments. J Stud Alcohol 2003;64:120–126
   PubMed Web of Science ®Google Scholar
• Rosenberg H, Mazzola J. Relationships among self-report assessments of craving in binge-drinking university students. Addict Behav 2007;32:2811–2818
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA, Brown GK. Manual for the BDI-II. San Antonio, TX: The Psychological Corporation, 1996
   Google Scholar
• Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129–138
   PubMedGoogle Scholar
• Muthén BO, Muthén BC. Mplus Version. 5.1 Ed.; Los Angeles, CA: Muthén & Muthén, 2008
   Google Scholar
• Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov B, Csaki F, eds. Second International Symposium on Information Theory. Budapest: Akademiai Kiado; 1973:267–281
   Google Scholar
• Raftery AE. Bayesian model selection in social research. In: Marsden PV, ed. Sociological methodology. Oxford: Blackwell, 1996, Vol. 26. pp. 111–163
   Google Scholar
• StataCorp. Stata Statistical Software: Release 10.1. College Station, TX: StataCorp LP 2010
   Google Scholar
• Fudala PJ, Bridge TP, Herbert S, Williford WO, Chiang CN, Jones K, Collins J, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med 2003;349:949–958
   PubMed Web of Science ®Google Scholar
• Preston KL, Epstein DH. Stress in the daily lives of cocaine and heroin users: relationship to mood, craving, relapse triggers, and cocaine use. Psychopharmacology (Berl) 2011;218:29–37
   PubMed Web of Science ®Google Scholar
• Brienza RS, Stein MD, Chen M, Gogineni A, Sobota M, Maksad J, Hu P, Clarke J. Depression among needle exchange program and methadone maintenance clients. J Subst Abuse Treat 2000;18:331–337
   PubMed Web of Science ®Google Scholar
• Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber C, Kleber H. Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome. Arch Gen Psychiatry 1982;39:151–156
   PubMed Web of Science ®Google Scholar
• Stanton L, McLeod C, Luckey B, Kissin WB, Sonnenfeld LJ. SAMHSA/CSAT Evaluation of the Buprenorphine Waiver Program. 2006. Available from: http://buprenorphine.samhsa.gov/ASAM_06_Final_Results.pdf [last accessed 5 June 2012]
   Google Scholar